Every law firm that pursues aggressive growth eventually confronts the same uncomfortable tension between expanding its reach and protecting what made it worth growing in the first place. Scott Rahn, Founding Partner
The legal profession has undergone a quiet but significant shift in professional dress standards since the COVID-19 pandemic changed how lawyers work. Before the pandemic, attorneys operated within well-established expectations about appropriate
More
London’s blue-chip index closed modestly higher on Friday, finishing the session at 10,816, up 23 points or 0.2%, ahead of the bank holiday weekend. The FTSE 100 reached a session high of
More
Halfords Group (HFD) emerged as one of the FTSE 250’s standout performers, with its shares jumping sharply after the company issued a stronger-than-expected trading outlook. The retailer and automotive services group has
More
Publicis Health has appointed Stephen Farquhar as its new chief executive officer, with the leadership transition taking effect on February 1. Farquhar steps into the role succeeding Alexandra von Plato, who has
More
Colorado’s attorney general Office Department of Law has filed proposed rules covering automated decision-making technology, with employers facing significant new compliance obligations starting January 1, 2027. The proposed “Automated Decision-Making Technology and
More
At just 18 years old, Jimmy Chilimigras has already achieved what most lawyers take decades to accomplish, graduating from law school and sitting a bar exam. Chilimigras recently completed his legal education
More
Bank of America (BAC) has issued a notable message to stock market investors, drawing attention from across the financial community as markets navigate an uncertain economic landscape. The bank’s commentary comes at
More
Hargreaves Lansdown, one of the UK’s largest investment platforms, regularly publishes its outlook on the key events and company updates expected to move markets in the coming week. Investors across the UK
More
Teva Pharmaceuticals (TEVA) has emerged as the stalking horse bidder for bankrupt BioXcel Therapeutics’ neuroscience portfolio in a deal worth up to $125 million. Connecticut-based BioXcel filed for Chapter 11 bankruptcy protection
More
The amended defamation lawsuit filed by Donald Trump against the New York Times has expanded significantly, now running to 62 pages of legal arguments and claims. Despite the increased length, the suit
More